Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 651 entries
Sorted by: Best Match Show Resources per page
Can experiences of authentic scientific inquiry result in transformational learning?

Broadening participation

Walker T.
GSID: i1N1Y2NLE8MJ
T Walker, T Molnar - Journal of Transformative Education, 2013 - journals.sagepub.com

This work examines the experience of secondary school students involved in authentic science inquiry (ASI) at the Canadian Light Source. We suggest this experience is a …

Cite
Walker, T., & Molnar, T. (2013). Can experiences of authentic scientific inquiry result in transformational learning?. Journal of transformative education, 11(4), 229-245.
Walker, Tracy, and Tim Molnar. "Can experiences of authentic scientific inquiry result in transformational learning?." Journal of transformative education 11.4 (2013): 229-245.
Copy Download .nbib Format: MLA
Career advancement as party patronage: Sponsored mobility into the Chinese administrative elite, 1949–1996

ADVANCE: Organizational Change for Gender Equity in STEM Academic Professions AND Program Evaluation

Walder AG.
GSID: XrmUkzV02sUJ
B Li, AG Walder - American Journal of Sociology, 2001 - journals.uchicago.edu

Core features of mobility regimes are obscured by models common in comparative research. Party patronage in China is apparent only in the timing of career events. Elites are chosen from among party members, but only some are eventually chosen....

Cite
Li, B., & Walder, A. G. (2001). Career advancement as party patronage: Sponsored mobility into the Chinese administrative elite, 1949–1996. American Journal of Sociology, 106(5), 1371-1408.
Li, Bobai, and Andrew G. Walder. "Career advancement as party patronage: Sponsored mobility into the Chinese administrative elite, 1949–1996." American Journal of Sociology 106.5 (2001): 1371-1408.
Copy Download .nbib Format: MLA
Key Concepts in Microbial Oceanography

Science and "broadening participation"

Walker G.
GSID: hen16W0ojlUJ
BC Bruno, K Achilles, G Walker… - AGU Fall Meeting …, 2008 - ui.adsabs.harvard.edu

The Center for Microbial Oceanography: Research and Education (C-MORE) is a multi-institution Science and Technology Center, established by the National Science Foundation in …

Cite
Bruno, B. C., Achilles, K., Walker, G., Weersing, K., & Team, A. (2008, December). Key Concepts in Microbial Oceanography. In AGU Fall Meeting Abstracts (Vol. 2008, pp. ED13D-06).
Bruno, B. C., et al. "Key Concepts in Microbial Oceanography." AGU Fall Meeting Abstracts. Vol. 2008. 2008.
Copy Download .nbib Format: MLA
Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis.

World journal of radiology

Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG.
PMID: 27027863
World J Radiol. 2016 Mar 28;8(3):308-15. doi: 10.4329/wjr.v8.i3.308.

AIM: To investigate the angiographic and volumetric effects of mammalian target of rapamycin (mTOR) inhibitors on angiomyolipomas (AMLs) in a case series of patients with tuberous sclerosis complex.METHODS: All patients who underwent catheter angiography prior to and following mTOR...

Cite
Sheth RA, Feldman AS, Paul E, et al. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World J Radiol. 2016;8(3):308-15doi: 10.4329/wjr.v8.i3.308.
Sheth, R. A., Feldman, A. S., Paul, E., Thiele, E. A., & Walker, T. G. (2016). Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World journal of radiology, 8(3), 308-15. https://doi.org/10.4329/wjr.v8.i3.308
Sheth, Rahul A, et al. "Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis." World journal of radiology vol. 8,3 (2016): 308-15. doi: https://doi.org/10.4329/wjr.v8.i3.308
Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World J Radiol. 2016 Mar 28;8(3):308-15. doi: 10.4329/wjr.v8.i3.308. PMID: 27027863; PMCID: PMC4807340.
Copy Download .nbib Format: NLM
Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

North ML, Walker TJ, Steacy LM, Hobsbawn BG, Allan RJ, Hackman F, Sun X, Day AG, Ellis AK.
PMID: 25024716
Allergy Asthma Clin Immunol. 2014 Jul 03;10(1):33. doi: 10.1186/1710-1492-10-33. eCollection 2014.

BACKGROUND: Oral antihistamines that target the histamine receptor-1, such as fexofenadine, offer suboptimal relief of allergic rhinitis-associated nasal congestion. Combinations with oral sympathomimetics, such as pseudoephedrine, relieve congestion but produce side effects. Previous animal and human studies with histamine...

Cite
North ML, Walker TJ, Steacy LM, et al. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014;10(1):33doi: 10.1186/1710-1492-10-33.
North, M. L., Walker, T. J., Steacy, L. M., Hobsbawn, B. G., Allan, R. J., Hackman, F., Sun, X., Day, A. G., & Ellis, A. K. (2014). Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 33. https://doi.org/10.1186/1710-1492-10-33
North, Michelle L, et al. "Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 10,1 (2014): 33. doi: https://doi.org/10.1186/1710-1492-10-33
North ML, Walker TJ, Steacy LM, Hobsbawn BG, Allan RJ, Hackman F, Sun X, Day AG, Ellis AK. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014 Jul 03;10(1):33. doi: 10.1186/1710-1492-10-33. eCollection 2014. PMID: 25024716; PMCID: PMC4094756.
Copy Download .nbib Format: NLM
Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment.

Oncoimmunology

Schuessler A, Walker DG, Khanna R.
PMID: 25083342
Oncoimmunology. 2014 Jun 25;3:e29381. doi: 10.4161/onci.29381. eCollection 2014.

Glioblastoma multiforme (GBM) has a very poor prognosis, despite multimodal therapy including surgery, radiation and chemotherapy. A novel adoptive immunotherapy that exploits the presence of cytomegalovirus antigens in malignant brain cancer cells has been shown to be safe and...

Cite
Schuessler A, Walker DG, Khanna R. Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment. Oncoimmunology. 2014;3:e29381doi: 10.4161/onci.29381.
Schuessler, A., Walker, D. G., & Khanna, R. (2014). Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment. Oncoimmunology, 3e29381. https://doi.org/10.4161/onci.29381
Schuessler, Andrea, et al. "Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment." Oncoimmunology vol. 3 (2014): e29381. doi: https://doi.org/10.4161/onci.29381
Schuessler A, Walker DG, Khanna R. Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment. Oncoimmunology. 2014 Jun 25;3:e29381. doi: 10.4161/onci.29381. eCollection 2014. PMID: 25083342; PMCID: PMC4108464.
Copy Download .nbib Format: NLM
Six years of a national antimicrobial stewardship programme in Scotland: where are we now?.

Antimicrobial resistance and infection control

Colligan C, Sneddon J, Bayne G, Malcolm W, Walker G, Nathwani D.
PMID: 26185619
Antimicrob Resist Infect Control. 2015 Jun 29;4:28. doi: 10.1186/s13756-015-0068-1. eCollection 2015.

BACKGROUND: The Scottish Antimicrobial Prescribing Group (SAPG) was established in 2008 to lead delivery of the national antimicrobial stewardship programme. We performed a national self-reported survey in 2014 to evaluate stewardship activities delivered by regional Antimicrobial Management Teams (AMTs)....

Cite
Colligan C, Sneddon J, Bayne G, et al. Six years of a national antimicrobial stewardship programme in Scotland: where are we now?. Antimicrob Resist Infect Control. 2015;4:28doi: 10.1186/s13756-015-0068-1.
Colligan, C., Sneddon, J., Bayne, G., Malcolm, W., Walker, G., Nathwani, D. (2015). Six years of a national antimicrobial stewardship programme in Scotland: where are we now?. Antimicrobial resistance and infection control, 428. https://doi.org/10.1186/s13756-015-0068-1
Colligan, Clare, et al. "Six years of a national antimicrobial stewardship programme in Scotland: where are we now?." Antimicrobial resistance and infection control vol. 4 (2015): 28. doi: https://doi.org/10.1186/s13756-015-0068-1
Colligan C, Sneddon J, Bayne G, Malcolm W, Walker G, Nathwani D. Six years of a national antimicrobial stewardship programme in Scotland: where are we now?. Antimicrob Resist Infect Control. 2015 Jun 29;4:28. doi: 10.1186/s13756-015-0068-1. eCollection 2015. PMID: 26185619; PMCID: PMC4504067.
Copy Download .nbib Format: NLM
A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.

AIDS research and therapy

Holt SG, Gracey DM, Levy MT, Mudge DW, Irish AB, Walker RG, Baer R, Sevastos J, Abbas R, Boyd MA.
PMID: 25745499
AIDS Res Ther. 2014 Nov 10;11:35. doi: 10.1186/1742-6405-11-35. eCollection 2014.

A number of antiviral agents used against Human Immunodeficiency Virus (HIV) infection and hepatitis B virus (HBV) mono or co-infection have been associated with real nephrotoxicity (including tenofovir disoproxil fumarate (TDF), atazanavir, indinavir and lopinavir) or apparent changes in...

Cite
Holt SG, Gracey DM, Levy MT, et al. A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS Res Ther. 2014;11:35doi: 10.1186/1742-6405-11-35.
Holt, S. G., Gracey, D. M., Levy, M. T., Mudge, D. W., Irish, A. B., Walker, R. G., Baer, R., Sevastos, J., Abbas, R., & Boyd, M. A. (2014). A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS research and therapy, 1135. https://doi.org/10.1186/1742-6405-11-35
Holt, Stephen G, et al. "A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection." AIDS research and therapy vol. 11 (2014): 35. doi: https://doi.org/10.1186/1742-6405-11-35
Holt SG, Gracey DM, Levy MT, Mudge DW, Irish AB, Walker RG, Baer R, Sevastos J, Abbas R, Boyd MA. A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS Res Ther. 2014 Nov 10;11:35. doi: 10.1186/1742-6405-11-35. eCollection 2014. PMID: 25745499; PMCID: PMC4350301.
Copy Download .nbib Format: NLM
Covalency-Driven Dimerization of Plutonium(IV) in a Hydroxamate Complex.

Inorganic chemistry

Silver MA, Cary SK, Stritzinger JT, Parker TG, Maron L, Albrecht-Schmitt TE.
PMID: 27228095
Inorg Chem. 2016 Jun 06;55(11):5092-4. doi: 10.1021/acs.inorgchem.6b00340. Epub 2016 May 26.

The reaction of formohydroxamic acid [NH(OH)CHO, FHA] with Pu(III) should result in stabilization of the trivalent oxidation state. However, slow oxidation to Pu(IV) occurs, which leads to formation of the dimeric plutonium(IV) formohydroxamate complex Pu2(FHA)8. In addition to being...

Cite
Silver MA, Cary SK, Stritzinger JT, et al. Covalency-Driven Dimerization of Plutonium(IV) in a Hydroxamate Complex. Inorg Chem. 2016;55(11):5092-4doi: 10.1021/acs.inorgchem.6b00340.
Silver, M. A., Cary, S. K., Stritzinger, J. T., Parker, T. G., Maron, L., & Albrecht-Schmitt, T. E. (2016). Covalency-Driven Dimerization of Plutonium(IV) in a Hydroxamate Complex. Inorganic chemistry, 55(11), 5092-4. https://doi.org/10.1021/acs.inorgchem.6b00340
Silver, Mark A, et al. "Covalency-Driven Dimerization of Plutonium(IV) in a Hydroxamate Complex." Inorganic chemistry vol. 55,11 (2016): 5092-4. doi: https://doi.org/10.1021/acs.inorgchem.6b00340
Silver MA, Cary SK, Stritzinger JT, Parker TG, Maron L, Albrecht-Schmitt TE. Covalency-Driven Dimerization of Plutonium(IV) in a Hydroxamate Complex. Inorg Chem. 2016 Jun 06;55(11):5092-4. doi: 10.1021/acs.inorgchem.6b00340. Epub 2016 May 26. PMID: 27228095.
Copy Download .nbib Format: NLM
Ballistic Phonon Penetration Depth in Amorphous Silicon Dioxide.

Nano letters

Yang L, Zhang Q, Cui Z, Gerboth M, Zhao Y, Xu TT, Walker DG, Li D.
PMID: 29087722
Nano Lett. 2017 Dec 13;17(12):7218-7225. doi: 10.1021/acs.nanolett.7b02380. Epub 2017 Nov 07.

Thermal transport in amorphous silicon dioxide (a-SiO

Cite
Yang L, Zhang Q, Cui Z, et al. Ballistic Phonon Penetration Depth in Amorphous Silicon Dioxide. Nano Lett. 2017;17(12):7218-7225doi: 10.1021/acs.nanolett.7b02380.
Yang, L., Zhang, Q., Cui, Z., Gerboth, M., Zhao, Y., Xu, T. T., Walker, D. G., & Li, D. (2017). Ballistic Phonon Penetration Depth in Amorphous Silicon Dioxide. Nano letters, 17(12), 7218-7225. https://doi.org/10.1021/acs.nanolett.7b02380
Yang, Lin, et al. "Ballistic Phonon Penetration Depth in Amorphous Silicon Dioxide." Nano letters vol. 17,12 (2017): 7218-7225. doi: https://doi.org/10.1021/acs.nanolett.7b02380
Yang L, Zhang Q, Cui Z, Gerboth M, Zhao Y, Xu TT, Walker DG, Li D. Ballistic Phonon Penetration Depth in Amorphous Silicon Dioxide. Nano Lett. 2017 Dec 13;17(12):7218-7225. doi: 10.1021/acs.nanolett.7b02380. Epub 2017 Nov 07. PMID: 29087722.
Copy Download .nbib Format: NLM
Making it Less Taxing: Reduced Dose Cabazitaxel in Castration-refractory Prostate Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))

Silverman R, Taylor S, Walker G, Sundar S.
PMID: 28139378
Clin Oncol (R Coll Radiol). 2017 Jun;29(6):394-395. doi: 10.1016/j.clon.2017.01.003. Epub 2017 Jan 27.

No abstract available.

Cite
Silverman R, Taylor S, Walker G, et al. Making it Less Taxing: Reduced Dose Cabazitaxel in Castration-refractory Prostate Cancer. Clin Oncol (R Coll Radiol). 2017;29(6):394-395doi: 10.1016/j.clon.2017.01.003.
Silverman, R., Taylor, S., Walker, G., & Sundar, S. (2017). Making it Less Taxing: Reduced Dose Cabazitaxel in Castration-refractory Prostate Cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 29(6), 394-395. https://doi.org/10.1016/j.clon.2017.01.003
Silverman, R, et al. "Making it Less Taxing: Reduced Dose Cabazitaxel in Castration-refractory Prostate Cancer." Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 29,6 (2017): 394-395. doi: https://doi.org/10.1016/j.clon.2017.01.003
Silverman R, Taylor S, Walker G, Sundar S. Making it Less Taxing: Reduced Dose Cabazitaxel in Castration-refractory Prostate Cancer. Clin Oncol (R Coll Radiol). 2017 Jun;29(6):394-395. doi: 10.1016/j.clon.2017.01.003. Epub 2017 Jan 27. PMID: 28139378.
Copy Download .nbib Format: NLM
Genomics and outbreak investigation: from sequence to consequence.

Genome medicine

Robinson ER, Walker TM, Pallen MJ.
PMID: 23673226
Genome Med. 2013 Apr 29;5(4):36. doi: 10.1186/gm440. eCollection 2013.

Outbreaks of infection can be devastating for individuals and societies. In this review, we examine the applications of new high-throughput sequencing approaches to the identification and characterization of outbreaks, focusing on the application of whole-genome sequencing (WGS) to outbreaks...

Cite
Robinson ER, Walker TM, Pallen MJ. Genomics and outbreak investigation: from sequence to consequence. Genome Med. 2013;5(4):36doi: 10.1186/gm440.
Robinson, E. R., Walker, T. M., & Pallen, M. J. (2013). Genomics and outbreak investigation: from sequence to consequence. Genome medicine, 5(4), 36. https://doi.org/10.1186/gm440
Robinson, Esther R, et al. "Genomics and outbreak investigation: from sequence to consequence." Genome medicine vol. 5,4 (2013): 36. doi: https://doi.org/10.1186/gm440
Robinson ER, Walker TM, Pallen MJ. Genomics and outbreak investigation: from sequence to consequence. Genome Med. 2013 Apr 29;5(4):36. doi: 10.1186/gm440. eCollection 2013. PMID: 23673226; PMCID: PMC3706975.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 651 entries